Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank78
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-4.95
↑ 87% vs avg
Percentile
P78
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-38.33
Historical baseline
PeriodValueYoY Change
2025-4.95-945.1%
2024-0.47+90.4%
2023-4.95-29.1%
2022-3.84+45.7%
2021-7.06-11.7%
2020-6.32+54.9%
2019-14.03-142.3%
2018-5.79+94.3%
2017-100.85+57.1%
2016-235.07-